Enteric Disease Testing Market size was valued at USD 3.81 Billion in 2023 and the total Enteric Disease Testing Market revenue is expected to grow at a CAGR of 3.6% from 2024 to 2030, reaching nearly USD 4.88 Billion by 2030.Enteric Disease Testing Market Overview:
Microorganisms such as viruses, bacteria, and parasites that cause gastro-intestinal illness are known as enteric diseases. Consumption of contaminated food or water causes these diseases. These diseases are sometimes passed from person to person.Enteric Disease Testing Market Dynamics:
Rising prevalence of Cholera worldwide is the major factor driving the market growth. Over the forecast period, the global enteric disease testing market is predicted to rise due to the high prevalence of cholera. In addition, an enteric disease outbreak is predicted to increase demand for enteric disease diagnostics. In August 2021, a salmonella outbreak was recorded in 47 states across the United States. In the third week of August, the Centers for Disease Control and Prevention stated that the number of recorded cases of salmonella newport infections had risen to 869, with 116 hospitalizations in 47 states. The enteric disease testing market is predicted to grow in response to increased government activities to raise public awareness about adequate sanitation, hygiene, and enteric infections.To know about the Research Methodology :- Request Free Sample Report Due to a weakened immune system, young children, newborns, individuals with disabilities, and the aged people are the most vulnerable to enteric infections. These disorders have to be recognised early in order to limit the risk of consequences. As a result, the rising geriatric population contributes to market growth. Previously, the diagnostic process for enteric diseases was dependent on conventional methods, which required specialised personnel and was a time-consuming procedure, resulting in increased death rates. These considerations, along with the cost-efficiency of technologically improved diagnostic systems, are driving demand for enteric disease testing. The key players and academic institutions have created an isothermal nucleic acid amplification-based diagnostic approach that uses enzymes to combine all of the temperature-dependent steps of PCR. Because this technology is so particular and sensitive, it may be used by healthcare facilities all over the world to identify and detect diseases quickly. This technique is expected to impose a positive impact on the market growth. The report has profiled twenty-one key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.
Enteric Disease Testing Market Segment Analysis:
The Global Enteric Disease Testing Market is segmented based on Disease Type, Test Type and End-Users. Based on Disease Type, the Bacterial Enteric Diseases segment accounts for a major market share. It involves various types of bacteria such as C. difficile, E. coli, Shigella, Salmonella, and Campylobacter. Enteric bacteria enter the body most commonly through the mouth. They are spread by contaminated food and drink, contact with animals or their habitats, and contact with an infected person's excrement. The segment accounted for more than XX% market share in 2023. Enteric bacteria can cause a chronic infection of the intestine, causing diarrhoea and weakening of the digestive tract. Cholera is predicted to affect 1,72,454 individuals worldwide each year, resulting in a higher fatality rate, states the WHO. Currently, there are vaccinations with higher efficacy that have been demonstrated to be effective in treating bacterial enteric illnesses. As a result, the increasing availability of better treatment alternatives will propel the segment forward. Based on Test Type, the molecular diagnostics segment is anticipated to dominate the global market. Traditional diagnostic approaches have been gradually replaced by newer quick antigen detection and molecular-based procedures as molecular diagnostics has progressed and commercially available assays have been available. Clostridioides difficile is the most common cause of nosocomial and antibiotic-related diarrhoea, as well as pseudomembranous colitis. C. difficile infection can be diagnosed using a number of FDA-approved procedures. AmpliVue C. difficile is a semiautomated assay that uses isothermal helicase-dependent amplification and hybridization in a cartridge/chip-based format (Quidel Diagnostics, San Diego, CA, USA). The United States, Canada, Japan, China, and Europe are expected to fuel the global Molecular Diagnostic Testing segment by registering a CAGR of XX% during the forecast period. China is anticipated to grow at a faster rate. The Asia-Pacific market is expected to reach US$607.7 million by 2030, led by countries like Australia, India, and South Korea. EntericDisease Testing Market Regional Insights:
North America is expected to dominate the global market during the forecast period. North America accounted for a market share of XX% in 2023. Because of the high cost of products and a high degree of customer awareness, North America dominates the market. In the United States, the market for enteric disease testing is expected to exceed $1 billion during the forecast period. Due to an increase in gastrointestinal illness diagnostic rates, multiple market players in the United States, technological improvements, significant R&D activities, and increased awareness about the disease the region is anticipated to grow at a significant rate. The report also helps in understanding the Global Enteric Disease Testing Market dynamics, structure by analyzing the market segments and project the Global Enteric Disease Testing Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Enteric Disease Testing Market make the report investor’s guide.Enteric Disease Testing Market, Key Developments:
ERADA Technology Alliance Ltd. (ERADA) launched the Saliva-based Malaria Asymptomatic and Asexual Rapid Test (SMAART), a saliva-based diagnostic tool for detecting parasites that cause malaria in March 2021.Enteric Disease Testing Industry Ecosystem
Global Enteric Disease Testing Market Scope: Inquire before buying
Global Enteric Disease Testing Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 3.81 Bn Forecast Period 2024 to 2030 CAGR: 3.6% Market Size in 2030: USD 4.88 Bn Segments Covered: by Disease Type Bacterial Enteric Diseases Viral Enteric Diseases Parasitic Enteric Diseases by Test Type Immunoassay testing Conventional testing Molecular diagnostic testing by End-Users Hospitals Research Labs Diagnostic Laboratories Enteric Disease Testing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Enteric Disease Testing Market Key Players are:
1.Alere Inc 2.Bio-Rad Laboratories 3.Quest Diagnostics 4.Becton Dickinson and Company 5.Cepheid 6.DiaSorin 7.Meridian BioSciences 8.Coris BioConcept 9.Trinity Biotech 10.Thermo Fisher Scientific Inc. 11.Mobidiag Ltd. 12.R-Biopharm 13.GlaxoSmithKline plc 14.Bharat Biotech 15.Sanofi 16.Janssen Global Services, LLC 17.Eli Lilly and Company 18.IDL Biotech AB (publ) 19.Merck & Co., Inc. 20.Novartis AG 21.Takeda Pharmaceutical CompanyFrequently Asked Questions:
1. Which region has the largest share in Enteric Disease Testing Market? Ans: North America region held the highest share in 2023. 2. What is the growth rate of Global Enteric Disease Testing Market? Ans: The Global Enteric Disease Testing Market is growing at a CAGR of 3.6% during forecasting period 2024-2030. 3. What is scope of the Global Enteric Disease Testing market report? Ans: Global market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Enteric Disease Testing market? Ans: The important key players in the market are – Alere Inc, Bio-Rad Laboratories, Quest Diagnostics, Becton Dickinson and Company, Cepheid, DiaSorin, Meridian BioSciences, Coris BioConcept, Trinity Biotech, Thermo Fisher Scientific Inc., Mobidiag Ltd., R-Biopharm, GlaxoSmithKline plc, Bharat Biotech, Sanofi, Janssen Global Services, LLC, Eli Lilly and Company, IDL Biotech AB (publ), Merck & Co., Inc., Novartis AG, and Takeda Pharmaceutical Company 5. What is the study period of this market? Ans: The Global market is studied from 2018 to 2030.
1. Enteric Disease Testing Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Enteric Disease Testing Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Key Players Benchmarking 2.4.1. Company Name 2.4.2. Business Segment 2.4.3. End-user Segment 2.4.4. Growth Rate (Y-O-Y %) 2.4.5. Revenue (2023) 2.4.6. Profit Margin 2.4.7. Market Share 2.4.8. Key Development 2.5. Market Size Estimation Methodology 2.5.1. Bottom-Up Approach 2.5.2. Top-Down Approach 2.6. Industry Ecosystem 2.6.1. Key Players in the Enteric Disease Testing Industry Ecosystem 2.6.2. Role of Companies in the Enteric Disease Testing Industry Ecosystem 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Mergers and Acquisitions Details 3. Enteric Disease Testing Market: Dynamics 3.1. Enteric Disease Testing Market Trends 3.2. Enteric Disease Testing Market Dynamics 3.2.1.1. Drivers 3.2.1.2. Restraints 3.2.1.3. Opportunities 3.2.1.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Customer Bargaining Power 3.3.2. Supplier Bargaining Power 3.3.3. Threat of New Entrants 3.3.4. Rivalry of Competitors 3.3.5. Threat of Substitute Products 3.4. PESTLE Analysis 3.5. Value Chain Analysis 3.6. Supply Chain Analysis 3.6.1. Research and Development 3.6.2. Production 3.6.3. Processing and Transforming 3.6.4. Transportation 3.6.5. Final Preparation 3.6.6. Distribution 3.7. Regulatory Landscape By Region 3.7.1. Regulations Related to Enteric Disease Testing Market 3.7.2. Regulatory Bodies, Government Agencies, and Other Organizations 3.8. Key Opinion Leader Analysis for the Enteric Disease Testing Industry 3.9. Price Analysis 3.9.1. Average Selling Price, By Type 3.9.2. Average Selling Price, By Region 3.10. Patent Analysis 3.10.1. Key Companies with the Highest number of Patents 3.10.2. Patent Registration Analysis 3.10.3. Number of Patents Granted Still 2024 3.10.4. Legal Status of Patents Field in Enteric Disease Testing Market 3.11. Technology Analysis 3.12. Investment and Funding Scenario 4. Enteric Disease Testing Market: Global Market Size and Forecast by Segmentation (By Value in USD Mn) (2023-2030) 4.1. Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 4.1.1. Bacterial Enteric Diseases 4.1.2. Viral Enteric Diseases 4.1.3. Parasitic Enteric Diseases 4.2. Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 4.2.1. Immunoassay Testing 4.2.2. Conventional Testing 4.2.3. Molecular Diagnostic Testing 4.3. Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 4.3.1. Hospitals 4.3.2. Research Labs 4.3.3. Diagnostic Laboratories 5. North America Enteric Disease Testing Market Size and Forecast by Segmentation (By Value in USD Million) (2023-2030) 5.1. North America Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 5.1.1. Bacterial Enteric Diseases 5.1.2. Viral Enteric Diseases 5.1.3. Parasitic Enteric Diseases 5.2. North America Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 5.2.1. Immunoassay Testing 5.2.2. Conventional Testing 5.2.3. Molecular Diagnostic Testing 5.3. North America Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 5.3.1. Hospitals 5.3.2. Research Labs 5.3.3. Diagnostic Laboratories 5.4. North America Enteric Disease Testing Market Size and Forecast, By Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 5.4.1.1.1. Bacterial Enteric Diseases 5.4.1.1.2. Viral Enteric Diseases 5.4.1.1.3. Parasitic Enteric Diseases 5.4.1.2. United States Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 5.4.1.2.1. Immunoassay Testing 5.4.1.2.2. Conventional Testing 5.4.1.2.3. Molecular Diagnostic Testing 5.4.1.3. United States Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 5.4.1.3.1. Hospitals 5.4.1.3.2. Research Labs 5.4.1.3.3. Diagnostic Laboratories 5.4.2. Canada 5.4.2.1. Canada Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 5.4.2.1.1. Bacterial Enteric Diseases 5.4.2.1.2. Viral Enteric Diseases 5.4.2.1.3. Parasitic Enteric Diseases 5.4.2.2. Canada Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 5.4.2.2.1. Immunoassay Testing 5.4.2.2.2. Conventional Testing 5.4.2.2.3. Molecular Diagnostic Testing 5.4.2.3. Canada Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 5.4.2.3.1. Hospitals 5.4.2.3.2. Research Labs 5.4.2.3.3. Diagnostic Laboratories 5.4.3. Mexico 5.4.3.1. Mexico Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 5.4.3.1.1. Bacterial Enteric Diseases 5.4.3.1.2. Viral Enteric Diseases 5.4.3.1.3. Parasitic Enteric Diseases 5.4.3.2. Mexico Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 5.4.3.2.1. Immunoassay Testing 5.4.3.2.2. Conventional Testing 5.4.3.2.3. Molecular Diagnostic Testing 5.4.3.3. Mexico Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 5.4.3.3.1. Hospitals 5.4.3.3.2. Research Labs 5.4.3.3.3. Diagnostic Laboratories 6. Europe Enteric Disease Testing Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 6.1. Europe Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 6.2. Europe Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 6.3. Europe Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 6.4. Europe Enteric Disease Testing Market Size and Forecast, By Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 6.4.1.2. United Kingdom Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 6.4.1.3. United Kingdom Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 6.4.2. France 6.4.2.1. France Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 6.4.2.2. France Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 6.4.2.3. France Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 6.4.3.2. Germany Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 6.4.3.3. Germany Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 6.4.4.2. Italy Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 6.4.4.3. Italy Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 6.4.5.2. Spain Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 6.4.5.3. Spain Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 6.4.6.2. Sweden Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 6.4.6.3. Sweden Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 6.4.7. Austria 6.4.7.1. Austria Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 6.4.7.2. Austria Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 6.4.7.3. Austria Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 6.4.8.2. Rest of Europe Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 6.4.8.3. Rest of Europe Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7. Asia Pacific Enteric Disease Testing Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 7.1. Asia Pacific Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.2. Asia Pacific Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.3. Asia Pacific Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7.4. Asia Pacific Enteric Disease Testing Market Size and Forecast, By Country (2023-2030) 7.4.1. China 7.4.1.1. China Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.4.1.2. China Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.4.1.3. China Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.4.2.2. S Korea Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.4.2.3. S Korea Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7.4.3. Japan 7.4.3.1. Japan Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.4.3.2. Japan Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.4.3.3. Japan Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7.4.4. India 7.4.4.1. India Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.4.4.2. India Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.4.4.3. India Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7.4.5. Australia 7.4.5.1. Australia Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.4.5.2. Australia Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.4.5.3. Australia Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7.4.6. Indonesia 7.4.6.1. Indonesia Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.4.6.2. Indonesia Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.4.6.3. Indonesia Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7.4.7. Malaysia 7.4.7.1. Malaysia Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.4.7.2. Malaysia Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.4.7.3. Malaysia Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7.4.8. Vietnam 7.4.8.1. Vietnam Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.4.8.2. Vietnam Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.4.8.3. Vietnam Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7.4.9. Taiwan 7.4.9.1. Taiwan Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.4.9.2. Taiwan Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.4.9.3. Taiwan Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 7.4.10.2. Rest of Asia Pacific Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 7.4.10.3. Rest of Asia Pacific Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 8. South America Enteric Disease Testing Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 8.1. South America Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 8.2. South America Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 8.3. South America Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 8.4. South America Enteric Disease Testing Market Size and Forecast, By Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 8.4.1.2. Brazil Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 8.4.1.3. Brazil Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 8.4.2.2. Argentina Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 8.4.2.3. Argentina Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest of South America Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 8.4.3.2. Rest of South America Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 8.4.3.3. Rest of South America Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 9. Middle East and Africa Enteric Disease Testing Market Size and Forecast By Segmentation (By Value USD Mn) (2023-2030) 9.1. Middle East and Africa Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 9.2. Middle East and Africa Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 9.3. Middle East and Africa Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 9.4. Middle East and Africa Enteric Disease Testing Market Size and Forecast, By Country (2023-2030) 9.4.1. South Africa 9.4.1.1. South Africa Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 9.4.1.2. South Africa Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 9.4.1.3. South Africa Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 9.4.2. GCC 9.4.2.1. GCC Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 9.4.2.2. GCC Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 9.4.2.3. GCC Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 9.4.3. Rest Of MEA 9.4.3.1. Rest Of MEA Enteric Disease Testing Market Size and Forecast, By Disease Type (2023-2030) 9.4.3.2. Rest Of MEA Enteric Disease Testing Market Size and Forecast, By Test Type (2023-2030) 9.4.3.3. Rest Of MEA Enteric Disease Testing Market Size and Forecast, By End-Users (2023-2030) 10. Company Profile: Key Players 10.1. Bio-Rad Laboratories 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview (Total Revenue, Segment Revenue, and Regional Revenue) 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Alere Inc 10.3. Quest Diagnostics 10.4. Becton Dickinson and Company 10.5. Cepheid 10.6. DiaSorin 10.7. Meridian BioSciences 10.8. Coris BioConcept 10.9. Trinity Biotech 10.10. Thermo Fisher Scientific Inc. 10.11. Mobidiag Ltd. 10.12. R-Biopharm 10.13. GlaxoSmithKline plc 10.14. Bharat Biotech 10.15. Sanofi 10.16. Janssen Global Services, LLC 10.17. Eli Lilly and Company 10.18. IDL Biotech AB (publ) 10.19. Merck & Co., Inc. 10.20. Novartis AG 10.21. Takeda Pharmaceutical Company 11. Key Findings 12. Analyst Recommendations 12.1. Attractive Opportunities for Players in the Enteric Disease Testing Market 12.2. Future Outlooks 13. Enteric Disease Testing Market: Research Methodology
